Trial Outcomes & Findings for Performance Study of Newly Developed Ostomy Products (NCT NCT01513330)

NCT ID: NCT01513330

Last Updated: 2014-01-09

Results Overview

Degree of leakage will be measured by a 25-point leakage scale (no leakage or up till 24 points of leakage), developed by Coloplast A/S. The subjects receive Petri dishes with pre-printed leakage scale on. The subject will place the Petri dish above the used baseplate and indicate where on the baseplate output appears. This is done by ticking of each area on the scale indicating the area of leakage.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

122 participants

Primary outcome timeframe

14 days

Results posted on

2014-01-09

Participant Flow

The subjects were recruited via sites and user data-bases in Denmark, Norway, Germany and France.

Participant milestones

Participant milestones
Measure
First SenSura Mio, Then Standard Care
The subjects first test SenSura Mio : Ostomy product - 1 piece closed bag and thereafter cross-over and test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)
First Standard Care, Then SenSura Mio
The subjects first test Standard Care Ostomy product 1 piece closed bags (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)and after cross-over test SenSura Mio 1-piece closed bags.
SenSura Mio First,
STARTED
64
58
SenSura Mio First,
COMPLETED
60
56
SenSura Mio First,
NOT COMPLETED
4
2
Standard Care First,
STARTED
60
56
Standard Care First,
COMPLETED
56
52
Standard Care First,
NOT COMPLETED
4
4

Reasons for withdrawal

Reasons for withdrawal
Measure
First SenSura Mio, Then Standard Care
The subjects first test SenSura Mio : Ostomy product - 1 piece closed bag and thereafter cross-over and test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)
First Standard Care, Then SenSura Mio
The subjects first test Standard Care Ostomy product 1 piece closed bags (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)and after cross-over test SenSura Mio 1-piece closed bags.
SenSura Mio First,
Adverse Event
2
0
SenSura Mio First,
Lack of Efficacy
0
1
SenSura Mio First,
Withdrawal by Subject
1
1
SenSura Mio First,
Other
1
0
Standard Care First,
Lack of Efficacy
2
2
Standard Care First,
Withdrawal by Subject
1
2
Standard Care First,
Other
1
0

Baseline Characteristics

Performance Study of Newly Developed Ostomy Products

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Entire Study Population
n=122 Participants
Entire study population = all participants enrolled in the study
Age, Continuous
65.3 years
STANDARD_DEVIATION 11.7 • n=5 Participants
Sex: Female, Male
Female
63 Participants
n=5 Participants
Sex: Female, Male
Male
59 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 14 days

Degree of leakage will be measured by a 25-point leakage scale (no leakage or up till 24 points of leakage), developed by Coloplast A/S. The subjects receive Petri dishes with pre-printed leakage scale on. The subject will place the Petri dish above the used baseplate and indicate where on the baseplate output appears. This is done by ticking of each area on the scale indicating the area of leakage.

Outcome measures

Outcome measures
Measure
SenSura Mio
n=2852 baseplates
SenSura Mio : Ostomy product - 1 piece closed bag
Standard Care
n=2810 baseplates
Standard Care : Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full Plate Leakage)
3.8 points on a scale
Standard Deviation 5.0
3.4 points on a scale
Standard Deviation 4.4

Adverse Events

SenSura Mio

Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths

Standard Care

Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
SenSura Mio
n=120 participants at risk
SenSura Mio : Ostomy product - 1 piece closed bag
Standard Care
n=118 participants at risk
Standard Care : Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Skin and subcutaneous tissue disorders
Itching
0.83%
1/120 • Number of events 1
0.85%
1/118 • Number of events 1
Skin and subcutaneous tissue disorders
Peristomal skin redness
1.7%
2/120 • Number of events 2
2.5%
3/118 • Number of events 3
Skin and subcutaneous tissue disorders
Peristomal skin erosion
0.83%
1/120 • Number of events 1
1.7%
2/118 • Number of events 2
Skin and subcutaneous tissue disorders
Peristomal allergic contact dermatitis
0.83%
1/120 • Number of events 1
0.85%
1/118 • Number of events 1
Skin and subcutaneous tissue disorders
Peristomal burns
0.83%
1/120 • Number of events 1
0.00%
0/118
Gastrointestinal disorders
Diarrhoea
0.83%
1/120 • Number of events 2
0.00%
0/118
Skin and subcutaneous tissue disorders
Infected toe
0.00%
0/120
0.85%
1/118 • Number of events 1
Skin and subcutaneous tissue disorders
Consumption of food leading to skin irritation
0.00%
0/120
0.85%
1/118 • Number of events 1
Skin and subcutaneous tissue disorders
Granulation in the peristomal area
1.7%
2/120 • Number of events 2
0.00%
0/118
Skin and subcutaneous tissue disorders
Pain in the peristomal area
0.83%
1/120 • Number of events 1
0.85%
1/118 • Number of events 1

Additional Information

Director of Clinical Trials

Coloplast A/S

Phone: +45 4911 3595

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place